Stay updated on Phase I Study of MIK665 Mcl-1 Inhibitor in Lymphoma or Myeloma Clinical Trial

Sign up to get notified when there's something new on the Phase I Study of MIK665 Mcl-1 Inhibitor in Lymphoma or Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Phase I Study of MIK665 Mcl-1 Inhibitor in Lymphoma or Myeloma Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    A new revision entry v3.5.4 is added to the Record History, and the prior entry v3.5.3 is removed, updating the visible version history to reflect the latest site maintenance release.
    Difference
    0.1%
    Check dated 2026-05-16T09:43:07.000Z thumbnail image
  4. Check
    24 days ago
    No Change Detected
  5. Check
    38 days ago
    Change Detected
    Summary
    The page now shows an updated ClinicalTrials.gov revision/version number (from v3.5.2 to v3.5.3) in the footer, indicating a platform release rather than a change to the trial’s record details.
    Difference
    0.1%
    Check dated 2026-04-24T22:27:37.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2; Removed Revision: v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-17T14:19:02.000Z thumbnail image
  7. Check
    74 days ago
    Change Detected
    Summary
    Revision: v3.5.0 added; Revision: v3.4.3 removed in the record history.
    Difference
    0.1%
    Check dated 2026-03-20T00:11:24.000Z thumbnail image
  8. Check
    81 days ago
    Change Detected
    Summary
    A new revision entry v3.4.3 was added and the previous revision v3.4.2 was removed from the record history.
    Difference
    0.1%
    Check dated 2026-03-12T19:36:24.000Z thumbnail image
  9. Check
    110 days ago
    Change Detected
    Summary
    New history entry 'Revision: v3.4.2' was added and an earlier 'Revision: v3.4.1' entry plus a site-wide funding notice were removed. These changes affect only the history metadata and do not modify study data or core page content.
    Difference
    0.7%
    Check dated 2026-02-11T20:36:51.000Z thumbnail image

Stay in the know with updates to Phase I Study of MIK665 Mcl-1 Inhibitor in Lymphoma or Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Phase I Study of MIK665 Mcl-1 Inhibitor in Lymphoma or Myeloma Clinical Trial page.